• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用胰蛋白酶从人红细胞基质中溶解活性补体受体1(CR1)并进行纯化。

Solubilization of active complement receptor type 1 (CR1) from human erythrocyte stroma with trypsin and its purification.

作者信息

Sugita Y, Nakano Y, Tomita M

出版信息

J Biochem. 1986 Nov;100(5):1193-200. doi: 10.1093/oxfordjournals.jbchem.a121823.

DOI:10.1093/oxfordjournals.jbchem.a121823
PMID:2950080
Abstract

Mild trypsinization of human erythrocyte stroma solubilized CR1 (complement receptor type 1, C3b/C4b receptor) without significant loss of decay-accelerating activity to C5 convertases on hemolytic intermediate cells (EAC 1-3b, P). The solubilized CR1 was purified using DEAE-Sephacel, C3-Sepharose, and anti-CR1-Sepharose column chromatographies. The purified material showed a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under non-reducing conditions, and its molecular weight was determined to be 175K, about 20K smaller than native CR1. Because the purified sample was separated into the several segments by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions, the molecule is considered to be nicked and those segments are associated by disulfide bonds. These results mean that a large portion of the CR1 molecule is present outside of the plasma membrane of erythrocytes, and the intramembranous and cytoplasmic domains are not necessary for decay-accelerating activity.

摘要

对人红细胞基质进行轻度胰蛋白酶处理可溶解CR1(补体受体1型,C3b/C4b受体),而对溶血中间细胞(EAC 1-3b,P)上的C5转化酶的衰变加速活性没有明显损失。使用DEAE-琼脂糖凝胶、C3-琼脂糖凝胶和抗CR1-琼脂糖凝胶柱色谱法对溶解的CR1进行纯化。在非还原条件下,纯化后的物质在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上显示出一条带,其分子量测定为175K,比天然CR1小约20K。由于在还原条件下,纯化后的样品在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中被分离成几个片段,因此认为该分子有切口,这些片段通过二硫键相连。这些结果表明,CR1分子的大部分存在于红细胞质膜之外,膜内和细胞质结构域对于衰变加速活性并非必需。

相似文献

1
Solubilization of active complement receptor type 1 (CR1) from human erythrocyte stroma with trypsin and its purification.用胰蛋白酶从人红细胞基质中溶解活性补体受体1(CR1)并进行纯化。
J Biochem. 1986 Nov;100(5):1193-200. doi: 10.1093/oxfordjournals.jbchem.a121823.
2
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).C3b/C4b受体(CR1)多态性变体的纯化与功能分析及其与H、C4b结合蛋白(C4bp)和衰变加速因子(DAF)的比较。
J Immunol. 1985 Oct;135(4):2661-7.
3
Isolation of decay-accelerating factor (DAF) from rabbit erythrocyte membranes.从兔红细胞膜中分离衰变加速因子(DAF)。
J Immunol Methods. 1987 Nov 23;104(1-2):123-30. doi: 10.1016/0022-1759(87)90495-9.
4
Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.从人红细胞中大规模分离1型补体受体(CR1)。蛋白水解片段化研究。
Biochem J. 1985 Dec 15;232(3):883-9. doi: 10.1042/bj2320883.
5
Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping.通过胰蛋白酶肽图谱分析C3b/C4b受体(CR1)多态性变体。
Mol Immunol. 1986 Jun;23(6):661-8. doi: 10.1016/0161-5890(86)90104-5.
6
Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.人血浆中C3b/C4b受体(CR1)可溶性形式的特性研究
J Immunol. 1985 May;134(5):3332-8.
7
Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.使用单克隆抗体通过亲和色谱法纯化的人C3b/C4b受体(CR1)的结构与功能研究
Complement. 1986;3(2):63-78. doi: 10.1159/000467882.
8
Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatography.
J Immunol Methods. 1985 Oct 10;82(2):303-13. doi: 10.1016/0022-1759(85)90362-x.
9
Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.人肾小球C3受体作为C3b/C4b补体1型(CR1)受体的特性
J Immunol. 1986 Feb 15;136(4):1373-7.
10
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.衰变加速因子(DAF)整合到细胞膜后对细胞表面补体激活的抑制作用。
J Exp Med. 1984 Nov 1;160(5):1558-78. doi: 10.1084/jem.160.5.1558.